Related Experiment Video
Updated: Jun 19, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
The value of surgery for retroperitoneal sarcoma
Sepideh Gholami1, Charlotte D Jacobs, Daniel S Kapp
1Stanford University School of Medicine, Stanford, CA 94305, USA.
Sarcoma
|October 15, 2009
Summary
Complete surgical resection is crucial for treating retroperitoneal sarcomas, especially high-grade ones. Tumor grade and stage significantly impact survival, while radiation and chemotherapy show limited benefits.
Area of Science:
- Surgical Oncology
- Medical Oncology
- Pathology
Background:
- Retroperitoneal sarcomas are rare, large, malignant tumors.
- Understanding prognostic factors is vital for effective treatment.
Purpose of the Study:
- To evaluate prognostic variables in localized retroperitoneal sarcoma.
- To assess the impact of complete surgical resection on survival.
Main Methods:
- Retrospective study of 41 patients with localized retroperitoneal sarcoma.
- Analysis of tumor grade, stage, treatment, and survival outcomes.
Main Results:
- High-grade tumors and advanced stage were common.
- Complete surgical resection was associated with improved 5-year survival (46%).
- Tumor grade significantly affected overall survival (P = .006).
Conclusions:
- Tumor grade, stage, and complete resection are key prognostic factors for high-grade retroperitoneal sarcomas.
- Complete surgical resection is the primary treatment modality.
- Radiation and chemotherapy did not significantly impact survival outcomes.
